Radio and PodcastRadio and PodcastLive Radio & Podcasts
Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer artwork
Science & Medicine

Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer

Oncology Times - OT Broadcasts from the iPad Archives by Oncology Times

Mar 3, 20259:41Science & Medicine

At the 2025 ASCO Genitourinary Cancers Symposium in San Francisco, the Phase III AFU-GETUG-20 trial reported that adjuvant androgen deprivation therapy did not improve outcomes when added to surgery for patients with hig...

About This Episode

Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer is an episode from Oncology Times - OT Broadcasts from the iPad Archives by Oncology Times. At the 2025 ASCO Genitourinary Cancers Symposium in San...

Podcast

This episode belongs to Oncology Times - OT Broadcasts from the iPad Archives.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Mar 3, 2025, 9:41 long, audio available.

Related Episodes

Continue listening to more episodes from Oncology Times - OT Broadcasts from the iPad Archives.